Data Characteristics in this Category
Contract Development and Manufacturing Organizations (CDMOs) in pharmacovigilance primarily source data from clinical trials, post-market surveillance, literature reviews, and spontaneous reporting systems. This data is largely unstructured text, including patient medical records, Individual Case Safety Reports (ICSRs), research reports, and medical journal articles. Data updates frequently, especially during clinical trials or early stages of new drug launches, leading to rapid data volume growth. Document structures vary. ICSRs typically follow ICH E2B standards, containing structured fields like patient demographics, drug information, adverse event descriptions, and medical terminology coding (e.g., MedDRA). However, the adverse event description itself is free text. Additionally, numerous unstructured research reports and literature exist, with fields and units varying based on specific study designs. These may involve complex and inconsistent units for dosage, frequency, and duration.
Constraints on Model Integration and Configuration from these Characteristics
The highly heterogeneous and rapidly updating nature of CDMO pharmacovigilance data imposes specific requirements on model integration and configuration. First, the high proportion of unstructured text demands strong natural language understanding capabilities from models. Models must accurately extract key information from free text, such as drug names, adverse reactions, dosages, administration routes, and times. Second, frequent data updates mean models need to support incremental learning or rapid retraining mechanisms to adapt to evolving data patterns and ensure model timeliness. Third, diverse document structures, particularly the mix of structured and unstructured data in ICSRs, require sophisticated preprocessing to unify data from different sources and formats. For example, accurate mapping and standardization of MedDRA codes and entity recognition in free text directly impact model performance. Finally, due to sensitive medical data, strict requirements exist for model privacy protection and data security compliance.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
maxContext | 4096 tokens | Pharmacovigilance reports often contain detailed descriptions; a sufficiently long context window is needed to capture complete information and avoid truncating critical details. |
Chunk size (Segment Length) | 800–1200 characters (characters) | Balances semantic completeness for long texts with model processing efficiency. Too short may fragment information; too long increases model processing burden. |
Recall count (Recall Count) | Top 5–10 entries (top 5–10 items) | Ensures retrieval of enough similar cases for context augmentation from a large volume of historical reports, balancing recall rate and model input length. |
Similarity threshold (Similarity Threshold) | 0.75 | Filters out irrelevant recall results, improving model input quality. This value requires adjustment based on actual data to avoid false positives or negatives. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Processing large PDFs or scanned reports can be time-consuming. Increase file parsing timeout to prevent processing failures due to timeouts. |
Model Provider | Select a model provider with pre-training in the medical domain | The pharmacovigilance domain requires high levels of specialized terminology and medical knowledge. Specialized models provide more accurate entity recognition and relation extraction. |
Three Common Mistakes
- Model vendor icon loading failure: Typically caused by network proxy configuration issues, preventing the model API's icon resources from loading from the specified CDN.
- Workflow nodes fail to effectively utilize the current large model context: Configuration does not explicitly specify that nodes should inherit or reuse context parameters from upstream nodes, leading to each node initializing its context independently.
- Low recognition rate for drug names or adverse reactions in free text when the model processes ICSR reports: This occurs because the model is not fine-tuned or pre-trained for the specific terminology and expression habits of the pharmacovigilance domain, resulting in insufficient specialized entity recognition.
How to Confirm Correct Configuration
- Submit a simulated ICSR report containing complex medical terminology. Check if the model output accurately identifies and extracts all key entities, such as drug names, adverse events, dosages, and administration routes. Validate against expected results.
- Test the model's concurrent performance and response time when processing large batches of reports via API calls. Ensure stable operation under expected load and check error logs for excessive timeouts or memory overflow errors.
- Upload pharmacovigilance documents in various formats (e.g., PDF, TXT, DOCX) to the knowledge base and perform retrieval tests. Confirm that parsing and recall effects for different document types meet expectations, especially the accuracy of semantic retrieval for unstructured text.
Note: The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.